A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity

AIM: The aim of this study was to develop a GX1-modified nanostructured lipid carrier (NLCs) and to evaluate its ability to improve the anti-gastric cancer tumor effects of paclitaxel (PTX). MAIN METHODS: The GX1-modified NLCs were synthesized and loaded with PTX (GX1-PTX-NLCs) by emulsion solvent e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Yufan, Zhao, Meina, Cao, Jinyi, Fan, Tingting, Bu, Wei, Yang, Yang, Li, Weiwei, Zhang, Wei, Qiao, Yi, Wang, Jingwen, Wen, Aidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297341/
https://www.ncbi.nlm.nih.gov/pubmed/32606603
http://dx.doi.org/10.2147/DDDT.S233023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297341/
https://www.ncbi.nlm.nih.gov/pubmed/32606603
http://dx.doi.org/10.2147/DDDT.S233023

Ejemplares similares